Background Factors Affecting Visual Acuity at Initial Visit in Eyes with Central Retinal Vein Occlusion: Multicenter Study in Japan

被引:4
作者
Kondo, Mineo [1 ]
Noma, Hidetaka [2 ]
Shimura, Masahiko [2 ]
Sugimoto, Masahiko [1 ]
Matsui, Yoshitsugu [1 ]
Kato, Kumiko [1 ]
Saishin, Yoshitsugu [3 ]
Ohji, Masahito [3 ]
Ishikawa, Hiroto [4 ]
Gomi, Fumi [4 ]
Iwata, Kensaku [5 ]
Yoshida, Shigeo [5 ]
Kusuhara, Sentaro [6 ]
Hirai, Hiromasa [7 ]
Ogata, Nahoko [7 ]
Hirano, Takao [8 ]
Murata, Toshinori [8 ]
Tsuboi, Kotaro [9 ]
Kamei, Motohiro [9 ]
Kinoshita, Takamasa [10 ]
Kuwayama, Soichiro [11 ]
Hirano, Yoshio [11 ]
Ohta, Manami [12 ]
Kimura, Kazuhiro [12 ]
Takayama, Kei [13 ]
Takeuchi, Masaru [13 ]
Takamura, Yoshihiro [14 ]
Okamoto, Fumiki [15 ]
Mitamura, Yoshinori [16 ]
Terasaki, Hiroto [17 ]
Sakamoto, Taiji [17 ]
机构
[1] Mie Univ, Dept Ophthalmol, Grad Sch Med, Tsu 5148507, Japan
[2] Tokyo Med Univ, Dept Ophthalmol, Hachioji Med Ctr, Hachioji 1930998, Japan
[3] Shiga Univ Med Sci, Dept Ophthalmol, Otsu 5202192, Japan
[4] Hyogo Coll Med, Dept Ophthalmol, Nishinomiya 6638501, Japan
[5] Kurume Univ, Dept Ophthalmol, Sch Med, Kurume 8300011, Japan
[6] Kobe Univ, Dept Surg, Div Ophthalmol, Grad Sch Med, Kobe 6500017, Japan
[7] Nara Med Univ, Dept Ophthalmol, Kashihara 6348521, Japan
[8] Shinshu Univ, Dept Ophthalmol, Sch Med, Matsumoto 3908621, Japan
[9] Aichi Med Univ, Dept Ophthalmol, Nagakute 4801195, Japan
[10] Sapporo City Gen Hosp, Dept Ophthalmol, Sapporo 0608604, Japan
[11] Nagoya City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Nagoya 4678601, Japan
[12] Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Ube 7558505, Japan
[13] Natl Def Med Coll, Dept Ophthalmol, Tokorozawa 3598513, Japan
[14] Univ Fukui, Fac Med Sci, Dept Ophthalmol, Yoshida 9101193, Japan
[15] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba 3058575, Japan
[16] Univ Tokushima, Inst Biomed Sci, Dept Ophthalmol, Grad Sch, Tokushima 7708503, Japan
[17] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan
关键词
central retinal vein occlusion; visual acuity; multicenter study; NATURAL-HISTORY; BLOOD-PRESSURE; RISK-FACTORS; PATHOGENESIS; RANIBIZUMAB; EPIDEMIOLOGY; THROMBOSIS;
D O I
10.3390/jcm10235619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To determine the baseline characteristics of patients with central retinal vein occlusion (CRVO) that were significantly associated with the best-corrected visual acuity (BCVA) at the initial examination. Methods: This was a retrospective multicenter study using the medical records registered in 17 ophthalmological institutions in Japan. Patients with untreated CRVO (>= 20-years-of-age) who were initially examined between January 2013 and December 2017 were studied. The patients' baseline factors that were significantly associated with the BCVA at the initial examination were determined by univariate and multivariate linear regression analyses. Results: Data from 517 eyes of 517 patients were analyzed. Univariate analyses showed that an older age (r = 0.194, p < 0.001) and the right eye (r = -0.103, p < 0.019) were significantly associated with poorer BCVA at the initial visit. Multivariate analyses also showed that an older age (beta = 0.191, p < 0.001) and the right eye (beta = -0.089, p = 0.041) were significantly associated with poorer BCVA at the initial visit. Conclusions: The results indicate that an older age, a known strong factor, and the right eye were significantly associated with poorer BCVA at the initial visit to the hospital. These results suggest that functional and/or anatomical differences between the right and left eyes may be involved in these results.
引用
收藏
页数:13
相关论文
共 34 条
  • [1] RANIBIZUMAB IN PREPROLIFERATIVE (ISCHEMIC) CENTRAL RETINAL VEIN OCCLUSION The Rubeosis Anti-VEGF (RAVE) Trial
    Brown, David M.
    Wykoff, Charles C.
    Wong, Tien P.
    Mariani, Angeline F.
    Croft, Daniel E.
    Schuetzle, Karri L.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (09): : 1728 - 1735
  • [2] Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
    Callizo, Josep
    Ziemssen, Focke
    Bertelmann, Thomas
    Feltgen, Nicolas
    Voegeler, Jessica
    Koch, Mirja
    Eter, Nicole
    Liakopoulos, Sandra
    Schmitz-Valckenberg, Steffen
    Spital, Georg
    [J]. CLINICAL OPHTHALMOLOGY, 2019, 13 : 2167 - 2179
  • [3] Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
    Campochiaro, Peter A.
    Brown, David M.
    Awh, Carl C.
    Lee, S. Young
    Gray, Sarah
    Saroj, Namrata
    Murahashi, Wendy Yee
    Rubio, Roman G.
    [J]. OPHTHALMOLOGY, 2011, 118 (10) : 2041 - 2049
  • [4] A study of inter-arm blood pressure differences in primary care
    Cassidy, P
    Jones, K
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (08) : 519 - 522
  • [5] LENS OPACITIES CLASSIFICATION SYSTEM-II (LOCS-II)
    CHYLACK, LT
    LESKE, MC
    MCCARTHY, D
    KHU, P
    KASHIWAGI, T
    SPERDUTO, R
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1989, 107 (07) : 991 - 997
  • [6] Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes
    Ciulla, Thomas
    Pollack, John S.
    Williams, David F.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (12) : 1696 - 1704
  • [7] Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486
  • [8] CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1434
  • [9] Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study
    Costa, Jorge Vasco
    Moura-Coelho, Nuno
    Abreu, Ana Carolina
    Neves, Pedro
    Ornelas, Mario
    Furtado, Maria Joao
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (02) : 343 - 350
  • [10] Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion
    Eleftheriadou, Maria
    Nicholson, Luke
    D'Alonzo, Giulia
    Addison, Peter K. F.
    [J]. OPHTHALMOLOGY AND THERAPY, 2019, 8 (02) : 289 - 296